Orum Therapeutics Venture Capital
5 known investors
Orum Rx is a clinical-stage biotech company developing a novel class of antibody-drug conjugates (ADCs) that pair antibody targeting with protein degraders. Its cell-selective degradation approach aims to improve the efficacy, safety, and half-life of conventional targeted protein degraders for disease treatment.
BiotechHealthtech
Investors Β· 5
Frequently asked questions
- What does Orum Therapeutics Venture Capital do?
- Orum Rx is a clinical-stage biotech company developing a novel class of antibody-drug conjugates (ADCs) that pair antibody targeting with protein degraders. Its cell-selective degradation approach aims to improve the efficacy, safety, and half-life of conventional targeted protein degraders for disease treatment.
- Who are Orum Therapeutics Venture Capital's investors?
- Orum Therapeutics Venture Capital's investors include Atinum Investment Co. Ltd., IMM Investment Japan, LB Investment, Solidus Investment, Xquared VC.